Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.Frontiers in Neurology|December 7, 2020
Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean OriginKaren Nuytemans, Farid Rajabli, Parker L Bussies, et al.Neuromodulation : Journal of the International Neuromodulation Society|May 24, 2019
Gender Disparities in Deep Brain Stimulation for Parkinson's DiseaseDanielle S Shpiner, Daniel G Di Luca, Iahn Cajigas, et al.Parkinsonism & Related Disorders|June 24, 2020
Trends of inpatient palliative care use among hospitalized patients with Parkinson's diseaseDaniel G Di Luca, Matthew Feldman, Sopiko Jimsheleishvili, et al.Tremor and Other Hyperkinetic Movements (New York, N.Y.)|May 20, 2024
Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily LivingLudy C Shih, Michael T Stevenson, Steven Bellows, et al.Movement Disorders Clinical Practice|April 18, 2023
Expanded and Independent Spanish Validation of the MDS-Non Motor Rating ScaleEsther Cubo, Sheng Luo, Pablo Martínez-Martín, et al.Journal of the Neurological Sciences|April 23, 2017
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard M Trosch, Alberto J Espay, Daniel Truong, et al.Clinical Neuropharmacology|September 15, 2015
Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With CreatineDavid K Simon, Cai Wu, Barbara C Tilley, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2005
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyDaniel Truong, Drake D Duane, Joseph Jankovic, et al.Neurology|October 4, 2017
Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scoresMaureen Leehey, Sheng Luo, Saloni Sharma, et al.Pageof 11